Hello Readers and New Subscribers,
As everyone enjoyed their weekend, we touted our 6 stock picks from last week and we watched a huge mover on Friday, GTx, Inc. (NASDAQ: GTXI).
The stock was upgraded Friday morning and surged over 20%. There ids still a lot of room to profit on this Hormone Development Biopharmaceutical company since analysts are targeting $7.
The company markets FARESTON (toremifene citrate) 60 mg ...
Continue Reading →
16
OCT
OCT
0
Share
